These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9124210)

  • 1. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
    Orazi A; Hromas RA; Neiman RS; Greiner TC; Lee CH; Rubin L; Haskins S; Heerema NA; Gharpure V; Abonour R; Srour EF; Cornetta K
    Am J Clin Pathol; 1997 Apr; 107(4):419-29. PubMed ID: 9124210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
    Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of posttransplantation lymphoproliferative disorders.
    Chadburn A; Cesarman E; Knowles DM
    Semin Diagn Pathol; 1997 Feb; 14(1):15-26. PubMed ID: 9044506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
    Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
    Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms.
    Chadburn A; Cesarman E; Liu YF; Addonizio L; Hsu D; Michler RE; Knowles DM
    Cancer; 1995 Jun; 75(11):2747-56. PubMed ID: 7743481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.
    Nador RG; Chadburn A; Gundappa G; Cesarman E; Said JW; Knowles DM
    Am J Surg Pathol; 2003 Mar; 27(3):293-302. PubMed ID: 12604885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
    Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
    Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
    N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.
    Kaplan MA; Ferry JA; Harris NL; Jacobson JO
    Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
    Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
    Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
    Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation.
    Koh BY; Rosenthal P; Medeiros LJ; Osorio RW; Roberts JP; Ascher NL; Gelb AB
    Arch Pathol Lab Med; 2001 Mar; 125(3):337-43. PubMed ID: 11231479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis.
    Davey DD; Kamat D; Laszewski M; Goeken JA; Kemp JD; Trigg ME; Purtilo DT; Davis J; Dick FR
    Mod Pathol; 1989 Jan; 2(1):27-34. PubMed ID: 2537974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study.
    Simon M; Bartram CR; Friedrich W; Arnold R; Schmeiser T; Hampl W; Müller-Hermelink HK; Heymer B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):307-19. PubMed ID: 1685038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.